Prediabetes management often emphasizes weight loss, but a long-term follow-up study found that for some older adults, ...

From mythical thorn bushes to flying aces, the remarkable history of one of medicine’s most routine procedures.

VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

The European Medicine Agency has recommended marketing authorization for a hybrid colchicine medicine for secondary prevention of atherothrombotic events in adults with stable coronary disease.

Artificial intelligence tools are beginning to move from research experiments into real-world emergency department workflows, raising new questions about how algorithms should be used in high-stakes ...

EMA advisers have backed a botulinum toxin for moderate to severe frown lines in adults, with reported onset of action as early as 8 hours and effects lasting 2-3 weeks.

CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of ...

European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age ...

European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.

Identifying three high-risk prediabetes types can help physicians decide when to add metformin, GLP-1/GIP agents, or SGLT2 ...

Women with endometriosis or adenomyosis face a higher risk for breast cancer and ovarian cancer than those without these ...

Intravenous iron supplementation may resolve iron deficiency in patients with heart failure with preserved ejection fraction ...